218 related articles for article (PubMed ID: 11454931)
1. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug.
Vaziri ND; Ding Y; Ni Z
J Pharmacol Exp Ther; 2001 Aug; 298(2):679-85. PubMed ID: 11454931
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity.
Polytarchou C; Papadimitriou E
Eur J Pharmacol; 2005 Mar; 510(1-2):31-8. PubMed ID: 15740722
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
4. Increased salt sensitivity induced by sensory denervation: role of superoxide.
Song WZ; Chen AF; Wang DH
Acta Pharmacol Sin; 2004 Dec; 25(12):1626-32. PubMed ID: 15569407
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress.
Kimura Y; Hirooka Y; Sagara Y; Ito K; Kishi T; Shimokawa H; Takeshita A; Sunagawa K
Circ Res; 2005 Feb; 96(2):252-60. PubMed ID: 15591232
[TBL] [Abstract][Full Text] [Related]
6. Dietary Zn deficiency does not influence systemic blood pressure and vascular nitric oxide signaling in normotensive rats.
Sato M; Kurihara N; Moridaira K; Sakamoto H; Tamura J; Wada O; Yanagisawa H
Biol Trace Elem Res; 2003 Feb; 91(2):157-72. PubMed ID: 12719611
[TBL] [Abstract][Full Text] [Related]
7. Effect of lead on nitric oxide synthase expression in coronary endothelial cells: role of superoxide.
Vaziri ND; Ding Y
Hypertension; 2001 Feb; 37(2):223-6. PubMed ID: 11230275
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function.
Thakali KM; Lau Y; Fink GD; Galligan JJ; Chen AF; Watts SW
J Cardiovasc Pharmacol; 2006 Jun; 47(6):742-50. PubMed ID: 16810074
[TBL] [Abstract][Full Text] [Related]
9. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
[TBL] [Abstract][Full Text] [Related]
10. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
Bojunga J; Dresar-Mayert B; Usadel KH; Kusterer K; Zeuzem S
Biochem Biophys Res Commun; 2004 Apr; 316(3):771-80. PubMed ID: 15033467
[TBL] [Abstract][Full Text] [Related]
11. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.
Ding Y; Vaziri ND; Gonick HC
Environ Res; 1998 Feb; 76(2):107-13. PubMed ID: 9515065
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.
Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK
Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension.
Vaziri ND; Lin CY; Farmand F; Sindhu RK
Kidney Int; 2003 Jan; 63(1):186-94. PubMed ID: 12472782
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
Majid DS; Kopkan L
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
[TBL] [Abstract][Full Text] [Related]
16. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat.
Zhang Y; Croft KD; Mori TA; Schyvens CG; McKenzie KU; Whitworth JA
Am J Hypertens; 2004 Mar; 17(3):260-5. PubMed ID: 15001201
[TBL] [Abstract][Full Text] [Related]
17. The effect of tempol on endothelium-dependent vasodilatation and blood pressure.
Simonsen U; Christensen FH; Buus NH
Pharmacol Ther; 2009 May; 122(2):109-24. PubMed ID: 19268689
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
19. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
20. Double-edged action of SOD mimetic in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
